Upload
jonah-fox
View
230
Download
0
Embed Size (px)
DESCRIPTION
Malaria Overview One of the most common & serious tropical diseases – million clinical cases worldwide –1-2 million deaths –41% of the world's population live in areas where malaria is transmitted –rising each year as drug resistance increases and health systems deteriorate Transmitted via the female Anopheles mosquito No vaccine
Citation preview
Malariapan-R Malaria cassette
Agenda• Disease overview
• Infectious agents
• Diagnosis
• pan-R Malaria cassette: specifications
• Conclusion
Malaria Overview• One of the most common & serious tropical diseases
– 300-500 million clinical cases worldwide– 1-2 million deaths– 41% of the world's population live in areas where
malaria is transmitted – rising each year as drug resistance increases and
health systems deteriorate
• Transmitted via the female Anopheles mosquito
• No vaccine
Global distribution
Infectious agents• Caused by 4 species of protozoal parasites from the
Plasmodium genus
– Plasmodium falciparum– Plasmodium vivax– Plasmodium ovale– Plasmodium malariae
• P. falciparum causes the most severe form of the disease
• If P. falciparum infection is not treated or the parasites are resistant to the drug-therapy, the disease can become life-threatening
Infectious agents• P.falciparum infection is most prevalent throughout Africa
• Increasing P.falciparum infections throughout Latin America, the Western Pacific and the Asia-Pacific regions
• Rapidly developing resistance to many of the drugs commonly used to treat malarial infections
• Expensive drug combination therapies now needed
• Accurate and rapid diagnosis of infection is more crucial than ever
Diagnosis• Accurate, Rapid & Confident diagnosis of infection is
crucial to providing effective treatment to manage the disease
• Misdiagnosis improper & unnecessary treatment
– Increased therapy costs
– Increased risk of drug resistance
Diagnosis• Accurate, Rapid & Confident diagnosis:
– Appropriate & effective drug treatment– Greater control over spread of infection
• Great advantage for health workers to be able to differentiate a P. falciparum malarial infection
• Increasing importance on the accurate diagnosis of parasitaemia prior to treatment
• P. falciparum drug resistance– expensive multi-drug regimes
Diagnosis• The pan-R Malaria Cassette can:
– Detect all pathogenic malaria antigens, in whole blood – Differentiate a P.falciparum infection
• Provides qualitative detection of:
– Plasmodium falciparum– Plasmodium vivax– Plasmodium ovale– Plasmodium malariae
Diagnosis• Provides patients and health-workers with a useful
diagnosis
– Rapid implementation of therapy
– Correct therapy
– Prioritise precious (& expensive) resources
– Save lives
SpecificationsName: pan-R Malaria CassetteCat. No. R-MAL01DExpiry: 18 monthsStorage: 4 – 28°C (room temperature, below 30°C)Antigen: HRP2, P. aldolaseSample: Whole bloodTest time: 15 minutesKit size: 25 tests & Collection devices, 1 bottle of
bufferProcedure: 2 well cassette, 5uL serum, 5 drops of
buffer
Procedure
Interpretation
Performance CharacteristicsTable 1: Sensitivity and Specificity of the Panbio pan-R Malaria Cassette P. falciparum versus non-P. falciparum Characterised Specimens
Specimen characterisation (Microscopy & PCR)
Panbio pan-R Malaria Cassette
Positive Negative Total
P.falciparum 262 11 273
Non P.falciparum 32 3 35
Negative 1 316 317
Total 295 330 625
Performance Characteristics95% CI*
Serological Sensitivity(P. falciparum)
= 262/273 96.0% 92.9 - 98.0%
Serological Sensitivity(non-P. falciparum)
= 32/35 91.4% 76.9 - 98.2%
Serological Specificity (Negative)
= 316/317 99.7% 98.3 - 100.0%
Relative Serological Agreement
= 610/625 97.6% 96.1 - 98.7%
*Confidence Interval
pan-R Malaria Cassette
Product brochure
Summary Card
Competitors• DiaMed OptiMAL
• Binax NOW
• Standard Diagnostics
• Core Diagnostics
Binax NOW OptiMAL
Panbio
Conclusion
www.panbio.com